Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections

Area of Science:

• Critical care medicine
• Infectious diseases
• Microbiology

Background:

• Nosocomial infections caused by gram-negative bacteria are increasing in intensive care units.
• Multidrug-resistant (MDR) gram-negative infections lead to high morbidity, mortality, and healthcare costs.
• Rising antimicrobial resistance to beta-lactams, including carbapenems, is a significant concern for pathogens like Pseudomonas aeruginosa, Acinetobacter baumannii, and Enterobacteriaceae.

Purpose of the Study:

• To highlight the growing threat of MDR gram-negative bacterial infections in acute/critical care settings.
• To emphasize the limitations of current treatment options for these infections.
• To discuss the role of antimicrobial stewardship and new therapeutic agents.

Main Methods:

• Review of current literature on gram-negative bacterial infections and antimicrobial resistance.
• Analysis of trends in nosocomial infections and treatment outcomes.
• Evaluation of the impact of antimicrobial stewardship programs.

Main Results:

• Significant increase in infections caused by MDR gram-negative bacteria in ICUs.
• Limited effective treatment options for infections caused by resistant gram-negative pathogens.
• Emergence of new therapeutic strategies, including beta-lactam/beta-lactamase inhibitor combinations.

Conclusions:

• MDR gram-negative bacterial infections pose a substantial challenge in healthcare settings.
• Antimicrobial stewardship is crucial for optimizing current treatments and combating resistance.
• Novel antimicrobial agents are expanding treatment options against resistant gram-negative bacteria.